Dr. L. Jay Katz, MD, is Director of the Glaucoma Service at Wills Eye Hospital and Professor of Ophthalmology at Jefferson Medical College in Philadelphia, PA.

Dr. Katz received his BA, summa cum laude, from Case Western Reserve University and his MD from Yale University School of Medicine, where he received an award for his medical thesis. He completed his ophthalmology residency at Yale and then moved to Wills Eye Hospital for his glaucoma subspecialty training. Dr. Katz has been on the faculty at Wills Eye ever since.

Dr. Katz has wide-ranging interests in glaucoma, including drug evaluation, the roles of laser and medical management in glaucoma treatment, and optic nerve scanning methodologies. In addition, he studies glaucoma surgical techniques, including new technologies such as the iStent. Lately, he has also been involved in studies of gene expression in primary open angle glaucoma and in the study of new instruments for intraocular pressure measurements. Dr. Katz has participated in major NEI/NIH collaborative studies, including the Glaucoma Laser Trial, the Advanced Glaucoma Intervention Study and the Collaborative Initial Glaucoma Treatment Study. He is a member of the iStent Study Group and the Low-Pressure Glaucoma Study Group.

The author of numerous journal articles and book chapters, Dr. Katz has delivered hundreds of lectures, teaching sessions and courses. He serves as a Section Editor for Survey of Ophthalmology and is on the editorial boards of Graefe's Archive for Clinical and Experimental Ophthalmology and the Journal of Glaucoma. He is also on the advisory boards of a number of pharmaceutical and glaucoma device companies, including Glaukos, Bausch & Lomb, Inotek Corp., Aerie Pharmaceutical, Allergan, Alcon and Merck. Dr. Katz's awards include the Senior Honor Award of the American Academy of Ophthalmology and the Yale University Eye Center Distinguished Alumnus Award.